আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
klexane stungulyf, lausn áfyllt sprauta 100 mg/ml
sanofi-aventis norge as - enoxaparinum natricum inn - stungulyf, lausn - áfyllt sprauta 100 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
klexane stungulyf, lausn í hettuglösum 100 mg/ml
sanofi-aventis norge as - enoxaparinum natricum inn - stungulyf, lausn - í hettuglösum 100 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
plaquenil filmuhúðuð tafla 200 mg
sanofi-aventis norge as - hydroxychloroquinum súlfat - filmuhúðuð tafla - 200 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sabrilex filmuhúðuð tafla 500 mg
sanofi-aventis norge as - vigabatrinum inn - filmuhúðuð tafla - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg
sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - Ónæmiskerfið sera og mótefni, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
spedra
menarini international operations luxembourg s.a. - avanafil - ristruflanir - lyf notuð við ristruflanir - meðferð við ristruflunum hjá fullorðnum körlum. Í röð fyrir spedra að vera virkt, kynferðislega örvun er krafist.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
zynquista
guidehouse germany gmbh - sotagliflozin - sykursýki, tegund 1 - lyf notuð við sykursýki - zynquista er ætlað sem viðbót til að insúlín meðferð til að bæta blóðsykursstjórnun í fullorðnir með tegund 1 sykursýki með líkama massi (Ætti) stærri 27 kg/m 2, sem hefur ekki tekist að ná fullnægjandi blóðsykursstjórnun þrátt fyrir bestu insúlín meðferð.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
nasacort nefúði, dreifa 55 míkróg/skammt
opella healthcare france s.a.s. - triamcinolonum acetóníð - nefúði, dreifa - 55 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
fludara filmuhúðuð tafla 10 mg
genzyme europe b.v. - fludarabinum fosfat - filmuhúðuð tafla - 10 mg